Automated selected reaction monitoring data analysis workflow for large-scale targeted proteomic studies

Nature Protocols

Volumn 8, Issue 8, 2013, Pages 1602-1619

  Surinova, Silvia ^a   Hüttenhain, Ruth ^a   Chang, Ching Yun ^b   Espona, Lucia ^a   Vitek, Olga ^b,c   Aebersold, Ruedi ^a,d  

^a Institute of Molecular Systems Biology   (Switzerland)

^b PURDUE UNIVERSITY   (United States)

^c Purdue University   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BLOOD; COMPUTER PROGRAM; FEMALE; HUMAN; INFORMATION PROCESSING; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; OVARY TUMOR; PLASMA; PROTEOMICS; STATISTICAL ANALYSIS; PROCEDURES;

AUTOMATIC DATA PROCESSING; BIOLOGICAL MARKERS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MASS SPECTROMETRY; OVARIAN NEOPLASMS; PLASMA; PROTEOMICS; SOFTWARE;

EID: 84894412736     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2013.091     Document Type: Article

References (18)

1. Picotti, P., Aebersold, R., Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat. Methods 9, 555–566 (2012).
2. Lange, V., Picotti, P., Domon, B., Aebersold, R., Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol. 4, 222 (2008).
3. Stahl-Zeng, J. et al. High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol. Cell Proteomics 6, 1809–1817 (2007).
4. Oberg, A.L., Vitek, O., Statistical design of quantitative mass spectrometry–based proteomic experiments. J. Proteome Res. 8, 2144–2156 (2009).
5. Anderson, L., Hunter, C.L., Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell Proteomics5, 573–588 (2006).
6. Picotti, P., Bodenmiller, B., Mueller, L., Domon, B., Aebersold, R., Full dynamic range proteome analysis of S. cerevisiaeby targeted proteomics. Cell 138, 795–806 (2009).
7. Addona, T. et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma. Nat. Biotechnol. 27, 631–642 (2009).
8. Cima, I. et al. Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc. Natl. Acad. Sci. USA 108, 3342–3347 (2011).
9. Huttenhain, R. et al. Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics. Sci. Transl. Med. 4, 142ra94 (2012).
10. Surinova, S. et al. On the development of plasma protein biomarkers. J. Proteome Res. 10, 5–16 (2011).
11. MacLean, B. et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966–968 (2010).
12. Reiter, L. et al. mProphet: automated data processing and statistical validation for large-scale SRM experiments. Nat. Methods 8, 430–435 (2011).
13. Chang, C.Y. et al. Protein significance analysis in selected reaction monitoring (SRM) measurements. Mol. Cell Proteomics 11, M111.O14662 (2012).
14. Farrah, T. et al. PASSEL: the PeptideAtlas SRMexperiment library. Proteomics 12, 1170–1175 (2012).
15. Storey, J.D., Tibshirani, R., Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100, 9440–9445 (2003).
16. Clough, T. et al. Protein quantification in label-free LC-MS experiments. J. Proteome Res. 8, 5275–5284 (2009).
17. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate—a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. Ser. B-Method. 57, 289–300 (1995).
18. Escher, C. et al. Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics 12, 1111–1121 (2012).